Plant Comparison
Lions mane vs Bitter Melon
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lions mane and Bitter Melon: they share 6 indicated uses (arthritis / joint pain, bloating, cancer (anticancer research), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Lions mane | Bitter Melon | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Bloating | 5/10 | 1/10 | Stronger for Lions mane |
| Cancer (anticancer research) | 1/10 | 9/10 | Stronger for Bitter Melon |
| Indigestion | 5/10 | 1/10 | Stronger for Lions mane |
| Inflammation (general) | 5/10 | 1/10 | Stronger for Lions mane |
| Skin irritation | 5/10 | 1/10 | Stronger for Lions mane |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Diterpenoid erinacines (concentrated in the mycelium) and aromatic hericenones (in the fruiting body) are the signature low-molecular-weight compounds that stimulate nerve growth factor synthesis and underlie the mushroom's neurotrophic and neuroprotective effects.
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from digestive action
inferred from anti-inflammatory action
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Mild gastrointestinal upset (nausea, bloating, diarrhoea) is the most common side effect. Rare allergic reactions can occur, particularly in individuals sensitive to mushrooms, and it may slightly lower blood sugar or have mild blood-thinning effects, so caution is advised for people on diabetes or anticoagulant medications.
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
External Ids
Botanical Description
Wood-decay fungus (not a true plant) forming a distinctive rounded, cushion-like fruiting body covered in long, dangling, tooth-like spines rather than gills or pores, resembling a white or cream 'lion's mane' or icicle cluster. It grows as a single mass rather than a typical cap-and-stem mushroom, on wounds or dead wood of hardwood trees.
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Habitat
Grows on wounds, dead or dying wood of hardwood trees (notably oak and beech) in temperate forests of the Northern Hemisphere; also widely cultivated commercially on hardwood logs or sawdust substrate.
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Harvesting
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then used fresh, dried, or processed into mycelium-based supplements.
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Traditional Uses
Lion's mane has a long East Asian culinary and medicinal tradition, valued in Chinese and Japanese medicine as a digestive tonic and, more recently, intensively studied for its unique ability to stimulate nerve growth factor, giving it a modern reputation as a neurotrophic and cognitive-support mushroom.[1]
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Preparations
Fruiting-body or mycelium extract standardised to erinacine or hericenone content, taken as capsules or powder; the form used in most clinical cognitive-support studies.
Dosage
A 49-week double-blind randomised trial in mild Alzheimer's disease used three erinacine A-enriched H. erinaceus mycelia capsules per day at 350 mg per capsule, i.e. 1050 mg daily. Other clinical studies of cognitive support commonly use around 1-3 g of dried fruiting body extract daily. Educational reference only, not a prescription.
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Szucko-Kociuba, I., Trzeciak-Ryczek, A., Kupnicka, P. and Chlubek, D (2023) 'Neurotrophic and Neuroprotective Effects of Hericium erinaceus', International Journal of Molecular Sciences, 24(21). doi:10.3390/ijms242115960 Preclinical
https://doi.org/10.3390/ijms242115960 - Contato, A.G. and Conte-Junior, C.A (2025) 'Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential - A Narrative Review', Nutrients, 17(8), pp. 1307. doi:10.3390/nu17081307 Meta-analysis / review
https://doi.org/10.3390/nu17081307 - Li, I.C. and Chang, H.H. and Lin, C.H. and Chen, W.P. and Lu, T.H. and Lee, L.Y. and Chen, Y.W. and Chen, Y.P. and Chen, C.C. and Lin, D.P (2020) 'Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study', Frontiers in Aging Neuroscience, 12, pp. 155. doi:10.3389/fnagi.2020.00155 Clinical study
https://doi.org/10.3389/fnagi.2020.00155 - Friedman, M (2015) 'Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds', Journal of Agricultural and Food Chemistry, 63(32), pp. 7108-7123. doi:10.1021/acs.jafc.5b02914 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.5b02914 - Xie, G. and Tang, L. and Xie, Y. and Xie, L (2022) 'Secondary Metabolites from Hericium erinaceus and Their Anti-Inflammatory Activities', Molecules, 27(7), pp. 2157. doi:10.3390/molecules27072157 Preclinical
https://doi.org/10.3390/molecules27072157 - Li, H., Feng, J., Liu, C., Hou, S., Meng, J., Liu, J.Y. and others (2024) 'Polysaccharides from an edible mushroom, Hericium erinaceus, alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.131251 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.131251 - Shi, X.Z., Zhang, X.Y., Wang, Y.Y., Zhao, Y.M. and Wang, J (2024) 'Polysaccharides from Hericium erinaceus and its immunomodulatory effects on RAW 264.7 macrophages', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.134947 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.134947 - Liu, J.H., Li, L., Shang, X.D., Zhang, J.L. and Tan, Q (2016) 'An experimental research on the anti-gastric-cancer activity of hericenone B extracted from Hericium erinaceus', 37(1), pp. 1--8. Traditional / reference
https://scholar.google.com/scholar?q=An%20experimental%20research%20on%20the%20anti-gastric-cancer%20activity%20of%20hericenone%20B%20extracted%20from%20Hericium%20erinaceus - Mori, K., Inatomi, S., Ouchi, K., Azumi, Y. and Tuchida, T (2009) 'Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial', 23(3), pp. 367--372. doi:10.1002/ptr.2634 Randomized trial
https://doi.org/10.1002/ptr.2634 - National Institutes of Health (2023) 'Hericium erinaceus'. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus - Pellegrino, R. and Gravina, A.G (2025) 'Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis', World Journal of Gastroenterology, 31(20). doi:10.3748/wjg.v31.i20.106615 Traditional / reference
https://doi.org/10.3748/wjg.v31.i20.106615 - Docherty, S., Doughty, F.L. and Smith, E.F (2023) 'The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study', Nutrients, 15(22). doi:10.3390/nu15224842 Randomized trial
https://doi.org/10.3390/nu15224842 - Surendran, G., Saye, J., Binti Mohd Jalil, S., Spreadborough, J., Duong, K., Shatwan, I.M. and others (2025) 'Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study', Frontiers in Nutrition. doi:10.3389/fnut.2025.1405796 Randomized trial
https://doi.org/10.3389/fnut.2025.1405796 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.